Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost–effectiveness analysis
Open Access
- 3 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (5) , 558-563
Abstract
Objectives. To assess the cost–effectiveness of providing practical training to general practitioners (GPs) in shoulder problems, and administering a local anaesthetic (lignocaine) vs steroidal (cortisone) injection. Methods. A cost–effectiveness analysis conducted alongside a cluster randomized trial with a factorial design, in general practices across five centres within the UK. A total of 155 participant GPs were randomized to receive training or no training with 200 participants randomized to either lignocaine or cortisone. Health care costs, quality-adjusted life years (QALYs) and incremental cost per QALY gained over 1 year estimated from a health system and a societal perspective were the main outcomes measured. Results. Over 1 year, training GPs costs on average an additional £211 (95% credibility interval −£237, £661) than no training and produces higher mean QALYs (0.075; −0.004, 0.154) per patient, yielding an incremental cost–effectiveness ratio of £2813 per QALY gained for trained GPs. Over the same period of 1 year, lignocaine costs an average of £122 more (−£232, £476) than cortisone and produces virtually no differential gain in mean QALYs (0.001; −0.068, 0.070), yielding an incremental cost per QALY gained of £122 000 for lignocaine compared with cortisone. Across a range of cost–effectiveness thresholds, cortisone is as cost effective to inject as lignocaine. The probability that training is cost effective is above 0.95 at thresholds above £20 000. Conclusions. Providing practical training to GPs about shoulder problems is cost effective and there is little uncertainty regarding this decision. The choice between lignocaine and cortisone is more uncertain and it is likely that there is significant value of further research to reduce this uncertainty. Trial registration. The International Standard Randomised Controlled Trial Number is 58 537 244.Keywords
This publication has 17 references indexed in Scilit:
- Shoulder acute pain in primary healthcare: is retraining effective for GP principals? SAPPHIRE--a randomized controlled trialRheumatology, 2008
- Effect of a short skills training course on competence and performance in general practiceMedical Education, 2000
- Shoulder disorders: a state-of-the-art reviewBest Practice & Research Clinical Rheumatology, 1999
- Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trialBMJ, 1998
- Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacyBMJ, 1998
- Modeling Valuations for EuroQol Health StatesMedical Care, 1997
- Physiotherapy for patients with soft tissue shoulder disorders: a systematic review of randomised clinical trialsBMJ, 1997
- Comparison of physiotherapy, manipulation, and corticosteroid injection for treating shoulder complaints in general practice: randomised, single blind studyBMJ, 1997
- Effectiveness of joint consultation sessions of general practitioners and orthopaedic surgeons for locomotor-system disordersThe Lancet, 1995
- Changing profile of joint disorders with age: findings from a postal survey of the population of Calderdale, West Yorkshire, United Kingdom.Annals of the Rheumatic Diseases, 1992